USPTO serial 79356181
ACCESSION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 19, 2025
- Examiner
- LEE, YATSYE ISADORA
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ACCESSION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Accession Healthcare Consulting Limited
GB
Other trademarks owned by Accession Healthcare Consulting Limited
Accession Healthcare Consulting Limited
GB
Other trademarks owned by Accession Healthcare Consulting Limited
Accession Healthcare Consulting Limited
GB
Other trademarks owned by Accession Healthcare Consulting Limited
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software for providing tools for market entry strategy, healthcare data analysis, care pathway analysis, cost and pricing insights, brand strategy development, value proposition creation, network building, healthcare program design, event planning, patient and prescription trend monitoring and analysis, patient experience audits, healthcare market studies, budget modeling, market access and training for use in the fields of pharmaceuticals, healthcare, medical treatment and health innovation; downloadable application software for providing tools for market entry strategy, healthcare data analysis, care pathway analysis, cost and pricing insights, brand strategy development, value proposition creation, network building, healthcare program design, event planning, patient and prescription trend monitoring and analysis, patient experience audits, healthcare market studies, budget modeling, market access and training for use in the fields of pharmaceuticals, healthcare, medical treatment and health innovation; downloadable software for developing customized software in the field of healthcare, medical data, healthcare marketing and healthcare business intelligence for others and for aggregating and analyzing, monitoring, tracking, sharing, and managing medical institution and patient disease, treatment, outcome, and experience data for use in the fields of pharmaceuticals, healthcare, medical treatment and health innovation utilising blockchain technology; data storage devices, namely, external computer hard drives featuring downloadable software for electronic storage of data and external computer hard drives featuring downloadable software for electronic storage of data; downloadable electronic publications, namely, magazines, manuals, catalogues, prospectuses, periodicals, journals, training manuals, educational materials, instructional literature and books for use in the fields of pharmaceuticals, healthcare, medical treatment and health innovation; downloadable manuals in electronic form for use in the fields of pharmaceuticals, healthcare, medical treatment and health innovation; training manuals in the form of a downloadable educational computer program featuring instruction in market access training and effective sales training for use by pharmaceutical companies and executives, healthcare professionals and managers; downloadable artificial intelligence and machine learning software for providing tools for market entry strategy, healthcare data analysis, care pathway analysis, cost and pricing insights, brand strategy development, value proposition creation, network building, healthcare program design, event planning, patient and prescription trend monitoring and analysis, patient experience audits, healthcare market studies, budget modeling, and market access and training for use in the fields of pharmaceuticals, healthcare, medical treatment and health innovation; all the aforementioned goods specifically connected with, relating to or for use in the healthcare and/or pharmaceutical industry | ACTIVE | — |
| 035 | Business consultancy and advisory services in the fields of pharmaceuticals, healthcare, medical treatment and health innovation; business assistance, management and administrative services; business analysis, research and information services; business auditing services; advertising, marketing and promotion services; providing consumer product information services in the fields of pharmaceuticals, healthcare, medical treatment and health innovation; provision of business data in the fields of pharmaceuticals, healthcare, medical treatment and health innovation; collection and systematisation of business data in computer databases, in the fields of pharmaceuticals, healthcare, medical treatment and health innovation; business data analysis services; data processing services; provision of business statistical information; business information, advisory and consultancy services relating to all these services; all the aforementioned services specifically connected with or relating to healthcare and/or the pharmaceutical industry | ACTIVE | — |
| 041 | Education services, namely, instruction in the fields of pharmaceuticals, healthcare, medical treatment and health innovation; organisation of conferences and exhibitions in the fields of pharmaceuticals, healthcare, medical treatment and health innovation for non-business and noncommercial purposes; audio recording production, video production, and multimedia production services; providing non-downloadable electronic publications, namely, magazines, manuals, catalogues, prospectuses, periodicals, journals, training manuals, educational materials, instructional literature and books in the fields of pharmaceuticals, healthcare, medical treatment and health innovation; publication of magazines, manuals, catalogues, prospectuses, periodicals, journals, training manuals, educational materials, instructional literature and books; conducting educational support programmes for healthcare professionals, namely, presentations, workshops, live training, computer education training and educational courses in the fields of pharmaceuticals, healthcare, medical treatment and health innovation; providing information, advisory and consultancy services on educational options relating to all these services; all the aforementioned services specifically connected with or relating to healthcare and/or the pharmaceutical industry | ACTIVE | — |
| 042 | Software development, programming and implementation; software as a service (SaaS) featuring software for providing tools for market entry strategy, healthcare data analysis, care pathway analysis, cost and pricing insights, brand strategy development, value proposition creation, network building, healthcare program design, event planning, patient and prescription trend monitoring and analysis, patient experience audits, healthcare market studies, budget modeling, market access training and sales training for use in the fields of pharmaceuticals, healthcare, medical treatment and health innovation; platform as a service (PaaS) featuring software platforms for providing tools for market entry strategy, healthcare data analysis, care pathway analysis, cost and pricing insights, brand strategy development, value proposition creation, network building, healthcare program design, event planning, patient and prescription trend monitoring and analysis, patient experience audits, healthcare market studies, budget modeling, market access and training for use in the fields of pharmaceuticals, healthcare, medical treatment and health innovation; blockchain as a service (BaaS) featuring blockchain software for aggregating and analyzing, monitoring, tracking, sharing, and managing medical institution and patient disease, treatment, outcome, and experience data for use in the fields of pharmaceuticals, healthcare, medical treatment and health innovation; hosting services namely for servers and websites; rental of a database server to third parties; developing customized software in the field of healthcare, medical data, care pathway analysis and healthcare business intelligence for others; rental of computer software for aggregating and analyzing, monitoring, tracking, sharing, and managing medical institution and patient disease, treatment, outcome, and experience data; IT consultancy, advisory and information services relating to design, installation, maintenance and repair of computer software; IT security protection and restoration services, namely, design and development of electronic data security systems and encrypted data recovery services; data duplication and conversion services, namely, media duplication of data and digital information, data conversion of electronic information, and related visualisation; data coding services, namely, data encryption and decoding services; medical and pharmacological research services; natural science research services; testing, authentication and quality control of computer software and data for use in the fields of pharmaceuticals, healthcare, medical treatment and health innovation to improve their scalability and performance; IT services, namely, design of information technology infrastructure for others for the pharmaceutical and healthcare industries; technical technology data analysis services in the fields of pharmaceuticals, healthcare, medical treatment and health innovation; providing technology information, advisory and consultancy services as it relates to the fields of medicine, pharmaceuticals, and healthcare industries; all the aforementioned services specifically connected with or relating to healthcare and/or the pharmaceutical industry | ACTIVE | — |
| 044 | Medical services; medical advisory services; medical analysis services for networks of healthcare providers, and relating to the diagnosis and treatment of patient cohorts; healthcare services, namely, integrated healthcare services within networks of healthcare providers programs; pharmaceutical and medical consultation services; monitoring of patients, namely, monitoring of medical data for medical diagnosis and treatment of patient cohorts; remote monitoring of data indicative of the health or condition of individuals, for medical diagnosis and treatment purposes; medical data analysis for networks of healthcare providers, and analysis relating to the diagnosis and treatment of patient cohorts; collation of medical, care pathway and healthcare utilisation information in the healthcare sector relating to patient and treatment trends and changing population health; providing medical information; healthcare information services; services for the preparation of medical reports relating to patient and treatment trends and changing population health; providing online medical record services, designed to provide healthcare providers and managers with custom tailored medical, care pathway and healthcare utilisation information in the fields of pharmaceuticals, healthcare, patient treatment and health innovation; providing medical information, advisory and consultancy services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Accession Healthcare Consulting Limited
- Other trademarks owned by Accession Healthcare Consulting Limited
- Other trademarks owned by Accession Healthcare Consulting Limited
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ACCESSION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 12, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 25, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 25, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 19, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 19, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 19, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 1, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 1, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 25, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 28, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 28, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 28, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 28, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 7, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 7, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 7, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 7, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 8, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 8, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 8, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 7, 2024 | ALIE | ASSIGNED TO LIE | — |
| Nov 6, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 6, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 15, 2024 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 21, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 1, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 1, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 9, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 9, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 9, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 6, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 5, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 5, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 1, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 7, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 7, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 27, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 26, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 26, 2023 | LOPR | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | — |
| May 18, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 13, 2023 | LOPT | LETTER OF PROTEST EVIDENCE FORWARDED | — |
| Dec 6, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 2, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 1, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |